Abbrea Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,760
| Closed | -$507K | – | 239 |
|
|
2024
Q1 | $507K | Buy |
4,760
+1,200
| +34% | +$128K | 0.07% | 161 |
|
|
2023
Q4 | $354K | Buy |
3,560
+1,275
| +56% | +$127K | 0.05% | 189 |
|
|
2023
Q3 | $236K | Sell |
2,285
-19
| -0.8% | -$1.96K | 0.04% | 210 |
|
|
2023
Q2 | $280K | Sell |
2,304
-23
| -1% | -$2.8K | 0.04% | 200 |
|
|
2023
Q1 | $357K | Hold |
2,327
| – | – | 0.06% | 180 |
|
|
2022
Q4 | $418K | Sell |
2,327
-107
| -4% | -$19.2K | 0.08% | 164 |
|
|
2022
Q3 | $288K | Hold |
2,434
| – | – | 0.05% | 185 |
|
|
2022
Q2 | $348K | Hold |
2,434
| – | – | 0.06% | 173 |
|
|
2022
Q1 | $419K | Hold |
2,434
| – | – | 0.06% | 174 |
|
|
2021
Q4 | $618K | Buy |
2,434
+19
| +0.8% | +$4.82K | 0.08% | 155 |
|
|
2021
Q3 | $929K | Sell |
2,415
-500
| -17% | -$192K | 0.14% | 116 |
|
|
2021
Q2 | $685K | Sell |
2,915
-100
| -3% | -$23.5K | 0.1% | 144 |
|
|
2021
Q1 | $395K | Buy |
+3,015
| New | +$395K | 0.07% | 170 |
|